The global market for Drug Discovery and Preclinical CRO was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Drug Discovery and Preclinical CRO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Drug Discovery and Preclinical CRO.
The Drug Discovery and Preclinical CRO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Drug Discovery and Preclinical CRO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Drug Discovery and Preclinical CRO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON plc
Pharmaron
Inotiv
ChemPartner
JOINN Laboratories
Evotec
Medicilon
Crown Bioscience
Champions Oncology
Frontage Laboratories
Viva Biotech
Hitgen Inc.
Shanghai Innostar
Segment by Type
Drug Discovery
Preclinical Research
Segment by Application
Pharmaceutical Company
Biotech Company
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Drug Discovery and Preclinical CRO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Please Note - This is an on demand report and will be delivered in 2 business days (48 hours) post payment.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Drug Discovery and Preclinical CRO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Drug Discovery
1.2.3 Preclinical Research
1.3 Market by Application
1.3.1 Global Drug Discovery and Preclinical CRO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical Company
1.3.3 Biotech Company
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Drug Discovery and Preclinical CRO Market Perspective (2020-2031)
2.2 Global Drug Discovery and Preclinical CRO Growth Trends by Region
2.2.1 Global Drug Discovery and Preclinical CRO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Drug Discovery and Preclinical CRO Historic Market Size by Region (2020-2025)
2.2.3 Drug Discovery and Preclinical CRO Forecasted Market Size by Region (2026-2031)
2.3 Drug Discovery and Preclinical CRO Market Dynamics
2.3.1 Drug Discovery and Preclinical CRO Industry Trends
2.3.2 Drug Discovery and Preclinical CRO Market Drivers
2.3.3 Drug Discovery and Preclinical CRO Market Challenges
2.3.4 Drug Discovery and Preclinical CRO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Drug Discovery and Preclinical CRO Players by Revenue
3.1.1 Global Top Drug Discovery and Preclinical CRO Players by Revenue (2020-2025)
3.1.2 Global Drug Discovery and Preclinical CRO Revenue Market Share by Players (2020-2025)
3.2 Global Drug Discovery and Preclinical CRO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Drug Discovery and Preclinical CRO Revenue
3.4 Global Drug Discovery and Preclinical CRO Market Concentration Ratio
3.4.1 Global Drug Discovery and Preclinical CRO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Drug Discovery and Preclinical CRO Revenue in 2024
3.5 Global Key Players of Drug Discovery and Preclinical CRO Head office and Area Served
3.6 Global Key Players of Drug Discovery and Preclinical CRO, Product and Application
3.7 Global Key Players of Drug Discovery and Preclinical CRO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Drug Discovery and Preclinical CRO Breakdown Data by Type
4.1 Global Drug Discovery and Preclinical CRO Historic Market Size by Type (2020-2025)
4.2 Global Drug Discovery and Preclinical CRO Forecasted Market Size by Type (2026-2031)
5 Drug Discovery and Preclinical CRO Breakdown Data by Application
5.1 Global Drug Discovery and Preclinical CRO Historic Market Size by Application (2020-2025)
5.2 Global Drug Discovery and Preclinical CRO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Drug Discovery and Preclinical CRO Market Size (2020-2031)
6.2 North America Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
6.4 North America Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Drug Discovery and Preclinical CRO Market Size (2020-2031)
7.2 Europe Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
7.4 Europe Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Drug Discovery and Preclinical CRO Market Size (2020-2031)
8.2 Asia-Pacific Drug Discovery and Preclinical CRO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Drug Discovery and Preclinical CRO Market Size by Region (2020-2025)
8.4 Asia-Pacific Drug Discovery and Preclinical CRO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Drug Discovery and Preclinical CRO Market Size (2020-2031)
9.2 Latin America Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
9.4 Latin America Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Drug Discovery and Preclinical CRO Market Size (2020-2031)
10.2 Middle East & Africa Drug Discovery and Preclinical CRO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Drug Discovery and Preclinical CRO Market Size by Country (2020-2025)
10.4 Middle East & Africa Drug Discovery and Preclinical CRO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Charles River
11.1.1 Charles River Company Details
11.1.2 Charles River Business Overview
11.1.3 Charles River Drug Discovery and Preclinical CRO Introduction
11.1.4 Charles River Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.1.5 Charles River Recent Development
11.2 Wuxi AppTec
11.2.1 Wuxi AppTec Company Details
11.2.2 Wuxi AppTec Business Overview
11.2.3 Wuxi AppTec Drug Discovery and Preclinical CRO Introduction
11.2.4 Wuxi AppTec Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.2.5 Wuxi AppTec Recent Development
11.3 Labcorp
11.3.1 Labcorp Company Details
11.3.2 Labcorp Business Overview
11.3.3 Labcorp Drug Discovery and Preclinical CRO Introduction
11.3.4 Labcorp Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.3.5 Labcorp Recent Development
11.4 Eurofins Scientific
11.4.1 Eurofins Scientific Company Details
11.4.2 Eurofins Scientific Business Overview
11.4.3 Eurofins Scientific Drug Discovery and Preclinical CRO Introduction
11.4.4 Eurofins Scientific Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.4.5 Eurofins Scientific Recent Development
11.5 PPD
11.5.1 PPD Company Details
11.5.2 PPD Business Overview
11.5.3 PPD Drug Discovery and Preclinical CRO Introduction
11.5.4 PPD Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.5.5 PPD Recent Development
11.6 ICON plc
11.6.1 ICON plc Company Details
11.6.2 ICON plc Business Overview
11.6.3 ICON plc Drug Discovery and Preclinical CRO Introduction
11.6.4 ICON plc Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.6.5 ICON plc Recent Development
11.7 Pharmaron
11.7.1 Pharmaron Company Details
11.7.2 Pharmaron Business Overview
11.7.3 Pharmaron Drug Discovery and Preclinical CRO Introduction
11.7.4 Pharmaron Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.7.5 Pharmaron Recent Development
11.8 Inotiv
11.8.1 Inotiv Company Details
11.8.2 Inotiv Business Overview
11.8.3 Inotiv Drug Discovery and Preclinical CRO Introduction
11.8.4 Inotiv Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.8.5 Inotiv Recent Development
11.9 ChemPartner
11.9.1 ChemPartner Company Details
11.9.2 ChemPartner Business Overview
11.9.3 ChemPartner Drug Discovery and Preclinical CRO Introduction
11.9.4 ChemPartner Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.9.5 ChemPartner Recent Development
11.10 JOINN Laboratories
11.10.1 JOINN Laboratories Company Details
11.10.2 JOINN Laboratories Business Overview
11.10.3 JOINN Laboratories Drug Discovery and Preclinical CRO Introduction
11.10.4 JOINN Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.10.5 JOINN Laboratories Recent Development
11.11 Evotec
11.11.1 Evotec Company Details
11.11.2 Evotec Business Overview
11.11.3 Evotec Drug Discovery and Preclinical CRO Introduction
11.11.4 Evotec Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.11.5 Evotec Recent Development
11.12 Medicilon
11.12.1 Medicilon Company Details
11.12.2 Medicilon Business Overview
11.12.3 Medicilon Drug Discovery and Preclinical CRO Introduction
11.12.4 Medicilon Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.12.5 Medicilon Recent Development
11.13 Crown Bioscience
11.13.1 Crown Bioscience Company Details
11.13.2 Crown Bioscience Business Overview
11.13.3 Crown Bioscience Drug Discovery and Preclinical CRO Introduction
11.13.4 Crown Bioscience Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.13.5 Crown Bioscience Recent Development
11.14 Champions Oncology
11.14.1 Champions Oncology Company Details
11.14.2 Champions Oncology Business Overview
11.14.3 Champions Oncology Drug Discovery and Preclinical CRO Introduction
11.14.4 Champions Oncology Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.14.5 Champions Oncology Recent Development
11.15 Frontage Laboratories
11.15.1 Frontage Laboratories Company Details
11.15.2 Frontage Laboratories Business Overview
11.15.3 Frontage Laboratories Drug Discovery and Preclinical CRO Introduction
11.15.4 Frontage Laboratories Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.15.5 Frontage Laboratories Recent Development
11.16 Viva Biotech
11.16.1 Viva Biotech Company Details
11.16.2 Viva Biotech Business Overview
11.16.3 Viva Biotech Drug Discovery and Preclinical CRO Introduction
11.16.4 Viva Biotech Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.16.5 Viva Biotech Recent Development
11.17 Hitgen Inc.
11.17.1 Hitgen Inc. Company Details
11.17.2 Hitgen Inc. Business Overview
11.17.3 Hitgen Inc. Drug Discovery and Preclinical CRO Introduction
11.17.4 Hitgen Inc. Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.17.5 Hitgen Inc. Recent Development
11.18 Shanghai Innostar
11.18.1 Shanghai Innostar Company Details
11.18.2 Shanghai Innostar Business Overview
11.18.3 Shanghai Innostar Drug Discovery and Preclinical CRO Introduction
11.18.4 Shanghai Innostar Revenue in Drug Discovery and Preclinical CRO Business (2020-2025)
11.18.5 Shanghai Innostar Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
Charles River
Wuxi AppTec
Labcorp
Eurofins Scientific
PPD
ICON plc
Pharmaron
Inotiv
ChemPartner
JOINN Laboratories
Evotec
Medicilon
Crown Bioscience
Champions Oncology
Frontage Laboratories
Viva Biotech
Hitgen Inc.
Shanghai Innostar
听
听
*If Applicable.
